Shopping News / Articles

Google News
healthday.com > healthpro-news > cardiovascular-diseases > global-findings-indicate-breast-cancer-and-a-fib-incidence-frequently-overlap

Overlapping Breast Cancer, A-Fib Incidence in 80 Countries/Territories

1+ hour, 59+ min ago  (277+ words) Global Findings Indicate Breast Cancer and A-Fib Incidence Frequently Overlap HealthDay THURSDAY, July 16, 2026 (HealthDay News) -- Eighty countries and territories, accounting for 39.60 percent of the world, exhibit overlapping breast cancer (BC) and atrial fibrillation (AF) incidence, according to a study published…...

HealthDay
healthday.com > healthpro-news > cancer > asco-lower-incidence-of-breast-cancer-seen-with-glp-1-receptor-agonist-exposure

ASCO: Lower Incidence of Breast Cancer Seen With GLP-1 Receptor Agonist Exposure

1+ mon, 1+ week ago  (77+ words) HealthDay - Health A to Z Health A to Z ASCO: Lower Incidence of Breast Cancer Seen With GLP-1 Receptor Agonist Exposure ASCO: First-Line Sunvozertinib Beats Chemo for Advanced NSCLC ASCO: Modest Accuracy Seen for Existing Breast Cancer Risk Prediction Models…...

HealthDay
healthday.com > healthpro-news > cancer > asco-modest-accuracy-seen-for-existing-breast-cancer-risk-prediction-models

ASCO: Modest Accuracy Seen for Existing Breast Cancer Risk Prediction Models

1+ mon, 1+ week ago  (77+ words) HealthDay - Health A to Z Health A to Z ASCO: Modest Accuracy Seen for Existing Breast Cancer Risk Prediction Models ASCO: App-Facilitated Palliative Care Improves HRQOL in Advanced Cancer GLP-1 Drugs Like Ozempic May Lower Breast Cancer Risk By About…...

HealthDay
healthday.com > health-news > cancer > glp-1-drugs-may-improve-breast-cancer-outcomes

GLP-1 Drugs May Improve Breast Cancer Outcomes

2+ mon, 2+ day ago  (67+ words) HealthDay - Health A to Z Health A to Z GLP-1 Drugs May Improve Breast Cancer Outcomes Ivermectin Prescriptions Doubled After Mel Gibson Cancer Cure Claim FDA Green Lights Bizengri Drug To Treat Rare, Aggressive Bile Duct Cancer Children Living Near…...

HealthDay
healthday.com > healthpro-news > cancer > fda-clears-arteraai-breast-for-breast-cancer-risk-stratification

FDA Clears ArteraAI Breast for Breast Cancer Risk Stratification

2+ mon, 3+ day ago  (55+ words) HealthDay - Health A to Z Health A to Z FDA Clears ArteraAI Breast for Breast Cancer Risk Stratification FDA Approves Bizengri for Rare Bile Duct Cancer FDA Moves to Real-Time Clinical Trial Patient Monitoring, Faster Drug Review New Treatment Improves…...

HealthDay
healthday.com > health-news > cancer > high-intensity-exercise-after-breast-cancer-surgery-helps-speed-recovery

High-Intensity Exercise After Breast Cancer Surgery Helps Speed Recovery

2+ mon, 2+ week ago  (202+ words) HealthDay Key TakeawaysCurrent restrictions on exercise after breast surgery may be too cautiousThree-month resistance training program significantly improves strength and mobilityResearchers say high-intensity resistance training should be a routine part of recovery.FRIDAY, May 1, 2026 (HealthDay News) — After breast cancer…...

healthday.com
healthday.com > healthday-tv > cancer > alternative-therapies-linked-to-lower-breast-cancer-survival-study-finds

Alternative Therapies Linked to Lower Breast Cancer Survival, Study Finds

3+ mon, 2+ week ago  (204+ words) healthday.com A new study suggests breast cancer patients who turn to complementary or alternative therapies may face worse survival outcomes.Researchers analyzed data from more than 2 million breast cancer patients across the U.S The majority received traditional therapies including…...

HealthDay
healthday.com > healthpro-news > pregnancy > global-maternal-mortality-ratio-reported-at-1905-deaths100000-livebirths-in-2023

Global Maternal Mortality Ratio Reported at 190.5 Deaths/100,000 Livebirths in 2023

3+ mon, 2+ week ago  (316+ words) HealthDay TUESDAY, March 31, 2026 (HealthDay News) -- In 2023, the global maternal mortality ratio (MMR) was 190.5 maternal deaths per 100,000 livebirths, according to a study published online March 26 in The Lancet Obstetrics, Gynaecology, & Women's Health.Jennifer Faith and members of the GBD 2023 Maternal Mortality…...

HealthDay
healthday.com > healthpro-news > cancer > circulating-tumor-dna-linked-to-poor-prognosis-in-her2-positive-early-breast-cancer

Circulating Tumor DNA Linked to Poor Prognosis in HER2-Positive Early Breast Cancer

6+ mon, 1+ day ago  (268+ words) HealthDay 15, 2026 (HealthDay News) -- For patients with human epidermal growth factor receptor 2 (HER2)-positive early breast cancer (EBC), the presence of circulating tumor (ct)DNA after neoadjuvant therapy (NAT) is associated with poor prognosis and may indicate the need for adjuvant ado-trastuzumab…...

HealthDay
healthday.com > health-news > cancer > hormone-drug-helps-fight-hormone-fueled-breast-cancer-trial-shows

Hormone Drug Helps Fight Hormone-Fueled Breast Cancer, Trial Shows

6+ mon, 1+ week ago  (465+ words) HealthDay...

Shopping

Please enter a search for detailed shopping results.